LOS ANGELES, March 24, 2025 (GLOBE NEWSWIRE) — As the face of artificial intelligence keeps changing, CrushOn.AI has outshined once again with its NSFW Character AI Girlfriend Chat facility. With its best-in-class technology, simplicity, and complete focus on privacy, CrushOn.AI is now one of the best AI chat websites to be trending in 2025. Whether […]
LOS ANGELES, March 24, 2025 (GLOBE NEWSWIRE) — As the face of artificial intelligence keeps changing, CrushOn.AI has outshined once again with its NSFW Character AI Girlfriend Chat facility. With its best-in-class technology, simplicity, and complete focus on privacy, CrushOn.AI is now one of the best AI chat websites to be trending in 2025. Whether
https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AppLovin Corporation (NASDAQ: APP) between May 10, 2023 and February 25, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline. So What: If you purchased AppLovin securities during the Class Period you
https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of e.l.f. Beauty, Inc. (“Elf”) (NYSE: ELF) between November 1, 2023 and November 19, 2024, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline. So what: If you purchased Elf securities during the Class
Jeito Capital co-leads the oversubscribed EUR78 million financing in Augustine Therapeutics to develop novel therapies for neuromuscular, cardio-metabolic and neurodegenerative diseases Proceeds from the financing will advance Augustine's lead candidate, AGT-100216, through a Phase 2 proof-of-concept clinical trial in Charcot-Marie-Tooth and support significant pipeline expansion into cardio-metabolic and neurodegenerative diseases This investment reinforces Jeito's expertise
A news report fromchinadaily.com.cn: Zhao Leji, chairman of China's National People's Congress (NPC) Standing Committee, delivered the work report of the national legislature to the third session of the 14th NPC held in March 2025. Click to learn more about the progress and outcomes achieved by the NPC Standing Committee in 2024. https://c212.net/c/img/favicon.png?sn=CN47750&sd=2025-03-24 View original
SHENZHEN, China, March 24, 2025 (GLOBE NEWSWIRE) — As the energy sector rapidly transitions towards cleaner, low-carbon, and more efficient solutions, cylindrical batteries have emerged as indispensable “energy capsule” in modern society, with end-user products demanding ever-more stringent battery performance. Recently, BAK Battery officially launched its tabless 18650 D-series products, bringing a comprehensive upgrade in
(NASDAQ:LAES),(NASDAQ:LAESV), Geneva, Switzerland, March 24, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”),a subsidiary of WISeKey, and WeCanGroup SA have entered into a strategic agreement under which SEALSQ will acquire a 30% equity stake in WeCanGroup. This collaboration aims to accelerate the adoption of blockchain-based security solutions within the Web 3.0 ecosystem,
(SWX:SANN), Pratteln, Switzerland, March 24, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that at its Capital Markets Day (CMD) in Zurich today, the Company will discuss the commercial progress with the global roll-out of AGAMREE(R) for the treatment of Duchenne Muscular Dystropy (DMD). The Company will also outline plans for further market expansion and provide
(Paris:VLA),(Paris:VLAP), Saint Herblain (France), March 24, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is rapidly intensifying in France's Island of La Reunion with its vaccine IXCHIQ(R). In agreement and with support from the local public health agency, the